Copenhagen, Denmark & Ingelheim, Germany: New studies mark an important advancement of Boehringer Ingelheim’s cardiometabolic focus areas obesity and NASH. The GLP-1/glucagon dual agonist BI 456906 may offer important benefits on both chronic weight management and NASH improvement. The Phase 2 trials for BI 456906 in obesity and NASH are part of the long-term […]
Month: April 2021
GLIDE Launches Inaugural Awards for Disease Elimination
Abu Dhabi, United Arab Emirates & London, United Kingdom: – New Abu Dhabi-based global health Institute launches its first disease elimination awards – 5 awards of up to USD200,000 each The Global Institute for Disease Elimination (GLIDE), a new Abu Dhabi-based global health Institute focused on eliminating infectious diseases of poverty, has launched The […]
LintonPharm Announces Authorization from China Health Authority (NMPA) to Proceed with a Phase 1/2 Trial Evaluating Catumaxomab for the treatment of Non-Muscle Invasive Bladder Cancer
Guangzhou, China: LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell engaging bispecific antibodies for cancer immunotherapy, today announced that China’s health authority, National Medical Products Administration (NMPA) authorized the company to proceed with a Phase 1/2 clinical trial (clinicaltrials.gov: NCT04799847) evaluating the safety and efficacy of […]
Games Industry Reflects on and Recommits to #PlayApartTogether Campaign at One Year Milestone
San Francisco, United States: Today, leaders from the global games industry who participated in #PlayApartTogether committed to reactivate the initiative launched one year ago, which encourages gamers everywhere to follow World Health Organization (WHO) health advice on COVID-19 prevention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210413005079/en/ Games Industry […]
Offender DNA Database Will Be Strong Deterrent to Repeat Crimes in India
New Delhi, Delhi, India: Building quality conviction and DNA profiling can effectively reduce repeat offense by more than 40% Increased severity of punishment not a strong deterrent of crime, reveal international studies As the country debates and scrutinizes the merits of instituting a national databank of crime scene DNA profiles, several experts from the […]
Diaceutics Appoints Yvanka Gilliam as Vice President of Operations, Asia Pacific
Parsippany, N.J., United States: Yvanka Gilliam brings a wealth of industry experience to the company, having worked in pharma for more than 20 years Prior to Diaceutics, she had roles in Kantar Health, IQVIA Asia Pacific and AstraZeneca Yvanka will be responsible for managing business development and operations in the APAC region Yvanka’s role […]
CORRECTING and REPLACING Illumina Named One of Singapore’s Best Employers
Singapore: First paragraph, second sentence of release should read: Illumina was second in Health Care and Equipment Services and placed 27th on the overall list. The updated release reads: ILLUMINA NAMED ONE OF SINGAPORE’S BEST EMPLOYERS Continues regional expansion with a focus on employees Illumina, Inc., today announced, for the […]
FLIR Wins DARPA Contract Worth Up to $20.5M to Develop Revolutionary New Protective Fabrics for Chem-Bio Defense
Arlington, Va., United States: FLIR Systems, Inc. (NASDAQ: FLIR) announced it has won a contract with the Defense Advanced Research Projects Agency (DARPA) to rapidly develop novel fabrics with embedded catalysts and chemistries that can fight and reduce chemical and biological threats upon contact. The revolutionary fabrics will be incorporated into protective suits and […]
Merck Advances ATR Inhibitor Berzosertib in Small Cell Lung Cancer With New Published Data and Initiation of Phase II Trial With Registrational Intent
Darmstadt, Germany: US National Cancer Institute led Phase II clinical study met its primary objective with 36% confirmed ORR, and showed durable responses1 A new company-sponsored, global clinical trial will further assess berzosertib in small cell lung cancer Merck is leading more than ten clinical trials across DNA Damage Response (DDR) pathways in various […]
SignaGuard and QuakeLogic Launch Breakthrough Structural Health Monitoring Technology for Earthquake-Prone Regions
Baltimore, Md., United States: California based QuakeLogic and SignaGuard (a division of MachineSense) announced today the development of a breakthrough process that combines the proprietary technology of both companies for structural health monitoring in earthquake-prone regions like the Himalayas. Frequent earthquakes along the Himalayan region have led scientists to agree that the entire belt is due […]